56921
Strep B ChromoSelect Selective Agar Base
suitable for microbiology, NutriSelect® Plus
Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych
About This Item
Kod UNSPSC:
41171606
NACRES:
NA.85
Polecane produkty
sterylność
non-sterile
Poziom jakości
Postać
powder
okres trwałości
limited shelf life, expiry date on the label
skład
agar, 15.0 g/L
buffers, 2.5 g/L
chromogenic mixture, 2.54 g/L
protein hydrolysate, 17.5 g/L
selective agents, 0.110 g/L
producent / nazwa handlowa
NutriSelect® Plus
pH końcowe
7.3±0.2 (25 °C)
Zastosowanie
clinical testing
veterinary
microbiology
temp. przechowywania
2-8°C
przydatność
Streptococcus spp.
Zastosowanie
Strep B ChromoSelect Selective Agar Base is recommended for selective isolation of Group B streptococci.
Uwaga dotycząca przygotowania
Suspend 37.65 grams in 1000 ml distilled water. Heat to boiling to dissolve the medium completely. DO NOT AUTOCLAVE. Cool to 45-50°C and aseptically add the rehydrated contents of one vial of Strep B ChromoSelect Selective Supplement (Cat. No. 92650). Mix well and pour in sterile Petri plates.
Przypis
We offer two media types: the superior granulated GranuCult® and the cost-efficient powdered NutriSelect® culture media, depending on your needs.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.
Informacje prawne
GRANUCULT is a registered trademark of Merck KGaA, Darmstadt, Germany
NutriSelect is a registered trademark of Merck KGaA, Darmstadt, Germany
This page may contain text that has been machine translated.
Kod klasy składowania
13 - Non Combustible Solids
Klasa zagrożenia wodnego (WGK)
WGK 2
Temperatura zapłonu (°F)
Not applicable
Temperatura zapłonu (°C)
Not applicable
Choose from one of the most recent versions:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
Murray, P.R., E.J. Baron, J.H. Jorgensen, M.A. Pfaller, and R. H. Yolken (Eds.)
Manual of Clinical Microbiology (2003)
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 45(RR-7), 1-24 (1996-05-31)
Group B streptococcus is a leading cause of serious neonatal infection. Most neonatal GBS infections can be prevented through the use of intrapartum antimicrobial prophylaxis in women who are at increased risk for transmitting the infection to their newborns. However
B F Anthony et al.
The Journal of infectious diseases, 137(5), 524-530 (1978-05-01)
A longitudinal, three-year study of the epidemiology of group B Streptococcus was conducted with repeated (four to 11) observations of 382 patients followed through pregnancy, delivery, and the postpartum period. Group B streptococci (2.3% of which were nonhemolytic) were isolated
Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.
Skontaktuj się z zespołem ds. pomocy technicznej